• About
  • Blog
  1. Home
  2. Blog
  3. Companies
  4. DVA

DaVita Inc.(DVA)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Care Facilities
DaVita Inc. logo

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Latest News & Analysis

Businesspeople seated at a round table in a modern office with a city skyline in the background
Jul 15, 2025

DaVita Inc. (DVA) Financial Strategy and Market Position Analysis

Comprehensive analysis of DaVita Inc.'s financial strategy, international growth, debt management, and market positioning for investors.

Read more →
Digital marketing workspace with computer and smartphone in an office with purple abstract decor
Jul 3, 2025

DaVita Inc. (DVA) Comprehensive Market Analysis: Financial Performance and Strategic Positioning

Explore DaVita Inc.'s latest financial results, strategic moves, and market positioning with data-driven insights on revenue growth and debt management.

Read more →
Businesswoman examines financial charts in a modern office with digital screens and a purple-themed background
Jun 30, 2025

DaVita Inc. (DVA) Market Analysis: Strategic Growth, Debt Management, and Latin America Expansion

DaVita advances value-based care with KCC model, strengthens balance sheet via $1B senior notes, and expands in Latin America amid competitive US dialysis market.

Read more →
DaVita stock decline: Analysis of earnings, market pressure, and Berkshire Hathaway's reduced stake.
Feb 21, 2025

DaVita's 2025 Outlook: Stock Plummets as Costs Rise and Buffett Trims Stake

DaVita (DVA) faces market headwinds amid a stock decline and Berkshire Hathaway's reduced stake, prompting concerns about its 2025 earnings outlook.

Read more →
Dialysis machine in a modern clinic setting.
Feb 20, 2025

DaVita’s 2025 Outlook: Berkshire Sale and Rising Costs Impact DVA

An in-depth analysis of DaVita's weak 2025 earnings outlook amid rising care costs and Berkshire Hathaway’s reduced stake.

Read more →
Stylized kidney with interconnected nodes on a blue and white gradient background, representing a network.
Feb 19, 2025

DaVita's 2025 Outlook: Navigating Kidney Care Challenges

A comprehensive update on [DVA]'s earnings, stock plunge, and strategic shifts amid rising costs and regulatory pressures.

Read more →

Professional-grade financial analysis tools for informed investment decisions.

Product

  • Features
  • Pricing

Resources

  • Blog
  • Knowledge Base
  • Community
  • Market Data

Company

  • About
  • Careers
  • Contact
  • Partners

Legal

  • Privacy
  • Terms
  • License
  • Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.